Potent anti-tumor activity against patient CLL, MM and AML by LAVA-051, a bispecific V9V2-T and type 1 NKT cell engager targeting CD1d.Roeland Lameris,Jurjen M. Ruben,Iris de Weerdt,Rob C. Roovers,Arnon P. Kater,Thilo A. Riedl,Victoria Iglesias,Ton Adang,Tanja D. de Gruijl,Paul W. H. I. Parren,Hans J. van der VlietCANCER RESEARCH(2021)引用 0|浏览14暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要